Epstein-barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9

Yu Yan Lan, Jenn-Ren Hsiao, Kung-Chao Chang, Jeffrey Shu Ming Chang, Chaio Wei Chen, Hsiao Ching Lai, Shih Yi Wu, Tzu Hao Yeh, Fang Hsin Chang, Wei Hung Lin, Ih Jen Su, Yao Chang

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is highly metastatic, and this malignant feature may be promoted by an EBV oncoprotein, latent membrane protein 2A (LMP2A). Acting as a signal regulator, LMP2A can enhance invasiveness and motility of epithelial cells. Downstream from the LMP2A-triggered signaling events, it is largely unknown what key effector proteins are induced and essentially promote cell invasion. In the present study, we found that in NPC cells, LMP2A upregulated matrix metalloproteinase 9 (MMP9), a metastasis-associated protease. LMP2A increased MMP9 expression at both the mRNA and protein levels. It also activated the MMP9 promoter, in which two AP-1 elements were required for the promoter activation. Among AP-1 transcription factors, Fra-1 was induced by LMP2A and is essential for LMP2A-triggered MMP9 expression. Induction of Fra-1 was dependent on the LMP2A-activated ERK1/2 pathway, and induction of the ERK1/2-Fra-1-MMP9 axis required PY motifs in the amino-terminal domain of LMP2A. Notably, LMP2A-promoted invasion of NPC cells was blocked when MMP9 expression, Fra-1 induction, or ERK1/2 activation was inhibited. In addition, we found an association of LMP2A with MMP9 expression in NPC tumor biopsy specimens, where Fra-1 was a major mediation factor. This study reveals an underlying mechanism of LMP2A-induced cell invasion, from signal transduction to upregulation of a critical protease. Considering that MMP9 can also be upregulated by another EBV oncoprotein, LMP1, this protease may be a pivotal effector at which the EBV-induced, invasion-promoting mechanisms converge, serving as an attractive therapeutic target for NPC treatment.

Original languageEnglish
Pages (from-to)6656-6667
Number of pages12
JournalJournal of Virology
Volume86
Issue number12
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Human herpesvirus 4
gelatinase B
Matrix Metalloproteinase 9
Human Herpesvirus 4
membrane proteins
carcinoma
Membrane Proteins
cells
cell invasion
Peptide Hydrolases
proteinases
Oncogene Proteins
Transcription Factor AP-1
Nasopharyngeal carcinoma
promoter regions
MAP Kinase Signaling System
metastasis
signal transduction
biopsy
Signal Transduction

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Lan, Yu Yan ; Hsiao, Jenn-Ren ; Chang, Kung-Chao ; Chang, Jeffrey Shu Ming ; Chen, Chaio Wei ; Lai, Hsiao Ching ; Wu, Shih Yi ; Yeh, Tzu Hao ; Chang, Fang Hsin ; Lin, Wei Hung ; Su, Ih Jen ; Chang, Yao. / Epstein-barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. In: Journal of Virology. 2012 ; Vol. 86, No. 12. pp. 6656-6667.
@article{3b18a943a8154d9eb694fe15608aa073,
title = "Epstein-barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9",
abstract = "Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is highly metastatic, and this malignant feature may be promoted by an EBV oncoprotein, latent membrane protein 2A (LMP2A). Acting as a signal regulator, LMP2A can enhance invasiveness and motility of epithelial cells. Downstream from the LMP2A-triggered signaling events, it is largely unknown what key effector proteins are induced and essentially promote cell invasion. In the present study, we found that in NPC cells, LMP2A upregulated matrix metalloproteinase 9 (MMP9), a metastasis-associated protease. LMP2A increased MMP9 expression at both the mRNA and protein levels. It also activated the MMP9 promoter, in which two AP-1 elements were required for the promoter activation. Among AP-1 transcription factors, Fra-1 was induced by LMP2A and is essential for LMP2A-triggered MMP9 expression. Induction of Fra-1 was dependent on the LMP2A-activated ERK1/2 pathway, and induction of the ERK1/2-Fra-1-MMP9 axis required PY motifs in the amino-terminal domain of LMP2A. Notably, LMP2A-promoted invasion of NPC cells was blocked when MMP9 expression, Fra-1 induction, or ERK1/2 activation was inhibited. In addition, we found an association of LMP2A with MMP9 expression in NPC tumor biopsy specimens, where Fra-1 was a major mediation factor. This study reveals an underlying mechanism of LMP2A-induced cell invasion, from signal transduction to upregulation of a critical protease. Considering that MMP9 can also be upregulated by another EBV oncoprotein, LMP1, this protease may be a pivotal effector at which the EBV-induced, invasion-promoting mechanisms converge, serving as an attractive therapeutic target for NPC treatment.",
author = "Lan, {Yu Yan} and Jenn-Ren Hsiao and Kung-Chao Chang and Chang, {Jeffrey Shu Ming} and Chen, {Chaio Wei} and Lai, {Hsiao Ching} and Wu, {Shih Yi} and Yeh, {Tzu Hao} and Chang, {Fang Hsin} and Lin, {Wei Hung} and Su, {Ih Jen} and Yao Chang",
year = "2012",
month = "7",
day = "1",
doi = "10.1128/JVI.00174-12",
language = "English",
volume = "86",
pages = "6656--6667",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "12",

}

Epstein-barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. / Lan, Yu Yan; Hsiao, Jenn-Ren; Chang, Kung-Chao; Chang, Jeffrey Shu Ming; Chen, Chaio Wei; Lai, Hsiao Ching; Wu, Shih Yi; Yeh, Tzu Hao; Chang, Fang Hsin; Lin, Wei Hung; Su, Ih Jen; Chang, Yao.

In: Journal of Virology, Vol. 86, No. 12, 01.07.2012, p. 6656-6667.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epstein-barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9

AU - Lan, Yu Yan

AU - Hsiao, Jenn-Ren

AU - Chang, Kung-Chao

AU - Chang, Jeffrey Shu Ming

AU - Chen, Chaio Wei

AU - Lai, Hsiao Ching

AU - Wu, Shih Yi

AU - Yeh, Tzu Hao

AU - Chang, Fang Hsin

AU - Lin, Wei Hung

AU - Su, Ih Jen

AU - Chang, Yao

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is highly metastatic, and this malignant feature may be promoted by an EBV oncoprotein, latent membrane protein 2A (LMP2A). Acting as a signal regulator, LMP2A can enhance invasiveness and motility of epithelial cells. Downstream from the LMP2A-triggered signaling events, it is largely unknown what key effector proteins are induced and essentially promote cell invasion. In the present study, we found that in NPC cells, LMP2A upregulated matrix metalloproteinase 9 (MMP9), a metastasis-associated protease. LMP2A increased MMP9 expression at both the mRNA and protein levels. It also activated the MMP9 promoter, in which two AP-1 elements were required for the promoter activation. Among AP-1 transcription factors, Fra-1 was induced by LMP2A and is essential for LMP2A-triggered MMP9 expression. Induction of Fra-1 was dependent on the LMP2A-activated ERK1/2 pathway, and induction of the ERK1/2-Fra-1-MMP9 axis required PY motifs in the amino-terminal domain of LMP2A. Notably, LMP2A-promoted invasion of NPC cells was blocked when MMP9 expression, Fra-1 induction, or ERK1/2 activation was inhibited. In addition, we found an association of LMP2A with MMP9 expression in NPC tumor biopsy specimens, where Fra-1 was a major mediation factor. This study reveals an underlying mechanism of LMP2A-induced cell invasion, from signal transduction to upregulation of a critical protease. Considering that MMP9 can also be upregulated by another EBV oncoprotein, LMP1, this protease may be a pivotal effector at which the EBV-induced, invasion-promoting mechanisms converge, serving as an attractive therapeutic target for NPC treatment.

AB - Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is highly metastatic, and this malignant feature may be promoted by an EBV oncoprotein, latent membrane protein 2A (LMP2A). Acting as a signal regulator, LMP2A can enhance invasiveness and motility of epithelial cells. Downstream from the LMP2A-triggered signaling events, it is largely unknown what key effector proteins are induced and essentially promote cell invasion. In the present study, we found that in NPC cells, LMP2A upregulated matrix metalloproteinase 9 (MMP9), a metastasis-associated protease. LMP2A increased MMP9 expression at both the mRNA and protein levels. It also activated the MMP9 promoter, in which two AP-1 elements were required for the promoter activation. Among AP-1 transcription factors, Fra-1 was induced by LMP2A and is essential for LMP2A-triggered MMP9 expression. Induction of Fra-1 was dependent on the LMP2A-activated ERK1/2 pathway, and induction of the ERK1/2-Fra-1-MMP9 axis required PY motifs in the amino-terminal domain of LMP2A. Notably, LMP2A-promoted invasion of NPC cells was blocked when MMP9 expression, Fra-1 induction, or ERK1/2 activation was inhibited. In addition, we found an association of LMP2A with MMP9 expression in NPC tumor biopsy specimens, where Fra-1 was a major mediation factor. This study reveals an underlying mechanism of LMP2A-induced cell invasion, from signal transduction to upregulation of a critical protease. Considering that MMP9 can also be upregulated by another EBV oncoprotein, LMP1, this protease may be a pivotal effector at which the EBV-induced, invasion-promoting mechanisms converge, serving as an attractive therapeutic target for NPC treatment.

UR - http://www.scopus.com/inward/record.url?scp=84864007453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864007453&partnerID=8YFLogxK

U2 - 10.1128/JVI.00174-12

DO - 10.1128/JVI.00174-12

M3 - Article

C2 - 22514348

AN - SCOPUS:84864007453

VL - 86

SP - 6656

EP - 6667

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 12

ER -